NL
DE
About Screenpoint Medical
ScreenPoint develops Deep Learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis. read moreAbout Screenpoint Medical
Smart AI for early breast cancer detection and diagnosis.
We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less invasive.
With the latest dedicated deep learning AI algorithms for breast cancer detection, Transpara® provides radiologists with clinically proven decision support tools. Transpara is trained on over 1 million trusted mammograms and can help with daily workflow and workload.
Transpara – the world’s first dedicated breast AI decision support solution for 2D and 3D mammography.
- Commercially available right now. It is CE marked and FDA cleared
- Multiple independent peer reviewed publications demonstrating improvement in accuracy and consistency
- Proven multivendor compatibility
Screenpoint Medical details
- CEO: Mark Koeniguer
- Affliated department: Radiology and Nuclear Medicine
- Researcher: Nico Karssemeijer
- Year of incorporation: 2014
